0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

Osteoimmunological impacts of micro/nanoplastics: systemic translocation, inflammatory responses, and bone remodeling disruption

Frontiers in Immunology 2026
Jinzhu Fan, Jinmeng Li, Chao Hao, Yigeng Hui

Summary

This review pulls together early research suggesting that tiny plastic particles we swallow (from food, water, and packaging) may not just pass through our gut—they could travel through the bloodstream and settle in bone marrow, where they might trigger inflammation and throw off the natural balance between building and breaking down bone. While the evidence is still preliminary and mostly from lab studies, it raises a concerning possibility that microplastic exposure could contribute to bone health problems over time, especially in children and older adults. More research is needed, but this is a good reminder to reduce plastic exposure where you reasonably can.

Ingested environmental micro- and nanoplastics (MNPs) may represent an emerging systemic health concern. Although toxicological research has mainly focused on the gastrointestinal tract, increasing evidence suggests that the highly vascularized bone marrow may also be a relevant site for MNP accumulation. This narrative review proposes a “gut-immune-bone” axis linking intestinal barrier disruption, systemic translocation, and potential deposition within the bone marrow niche. Current experimental evidence, together with limited human detection data, suggests that MNPs may disturb osteoimmunological homeostasis by impairing osteogenesis and promoting macrophage-associated osteoclastogenesis, thereby favoring bone remodeling imbalance. We summarize potential mechanisms, including oxidative stress, nuclear factor-κB (NF-κB) signaling, NOD-like receptor protein 3 (NLRP3) inflammasome activation, gut microbiota dysbiosis, endocrine disruption, and MNP-heavy metal co-exposure. We also discuss susceptible pediatric and geriatric populations and highlight the need to incorporate osteoimmunological endpoints into future MNP risk assessment.

Share this paper